ArticleClinics (Sao Paulo, Brazil)2026

Cardiac safety of sofosbuvir-based direct-acting antivirals in hepatitis C patients with pre-existing heart disease.

Amr Shaaban Hanafy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.